Rodor J, Klimi E, Brown S, Krilis G, Braga L, Ring N
Mol Ther. 2024; 33(2):615-630.
PMID: 39736815
PMC: 11852670.
DOI: 10.1016/j.ymthe.2024.12.037.
Lim E, Varcoe R
J Clin Med. 2024; 13(6).
PMID: 38541981
PMC: 10970957.
DOI: 10.3390/jcm13061757.
Chen D, Krinsky C, Phillips M, Allred C, Khan A, Liu L
Bioeng Transl Med. 2024; 9(2):e10618.
PMID: 38435812
PMC: 10905536.
DOI: 10.1002/btm2.10618.
Das A, Mehrotra S, Kumar A
J Funct Biomater. 2023; 14(11).
PMID: 37998113
PMC: 10672426.
DOI: 10.3390/jfb14110544.
Alghrairi M, Sulaiman N, Mutashar S
Sensors (Basel). 2020; 20(15).
PMID: 32752231
PMC: 7435700.
DOI: 10.3390/s20154303.
The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling.
Mahmoud A, Ballantyne M, Miscianinov V, Pinel K, Hung J, Scanlon J
Circ Res. 2019; 125(5):535-551.
PMID: 31339449
PMC: 6693924.
DOI: 10.1161/CIRCRESAHA.119.314876.
Sirolimus-loaded CaP coating on Co-Cr alloy for drug-eluting stent.
Yang J, Lee I, Cui F
Regen Biomater. 2016; 3(3):167-71.
PMID: 27252886
PMC: 4881617.
DOI: 10.1093/rb/rbw018.
Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.
Oda T, Okamura T, Yamada J, Miyagi N, Uehara H, Nao T
Heart Vessels. 2015; 31(4):449-56.
PMID: 25614415
DOI: 10.1007/s00380-015-0630-z.
A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion.
Zhu X, Braatz R
J Biomed Mater Res A. 2014; 103(7):2269-79.
PMID: 25345656
PMC: 4454334.
DOI: 10.1002/jbm.a.35357.
Modeling and analysis of drug-eluting stents with biodegradable PLGA coating: consequences on intravascular drug delivery.
Zhu X, Braatz R
J Biomech Eng. 2014; 136(11).
PMID: 25084767
PMC: 4181344.
DOI: 10.1115/1.4028135.
Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention.
Scott R, Panitch A
Biomacromolecules. 2014; 15(8):2825-32.
PMID: 24964369
PMC: 4130236.
DOI: 10.1021/bm5007757.
Everolimus-eluting coronary stents.
Saez A, Moreno R
Med Devices (Auckl). 2012; 3:51-6.
PMID: 22915921
PMC: 3417865.
DOI: 10.2147/MDER.S4422.
Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.
Zhu X, Pack D, Braatz R
Comput Methods Biomech Biomed Engin. 2012; 17(3):187-98.
PMID: 22512464
PMC: 3442148.
DOI: 10.1080/10255842.2012.672815.
Magnetic stents retain nanoparticle-bound antirestenotic drugs transported by lipid microbubbles.
Rathel T, Mannell H, Pircher J, Gleich B, Pohl U, Krotz F
Pharm Res. 2011; 29(5):1295-307.
PMID: 22189692
DOI: 10.1007/s11095-011-0643-y.
Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.
Lee M, Garvey S, Baras A, Lemmon J, Gomez M, Schoppee Bortz P
Hum Mol Genet. 2009; 19(3):468-79.
PMID: 19926569
PMC: 2798722.
DOI: 10.1093/hmg/ddp511.
Current trends in coronary revascularization.
Dunlay S, Rihal C, Sundt T, Gerber Y, Roger V
Curr Treat Options Cardiovasc Med. 2009; 11(1):61-70.
PMID: 19141262
DOI: 10.1007/s11936-009-0007-7.
